Log in to save to my catalogue

Recent Advances in 64Cu/67Cu-Based Radiopharmaceuticals

Recent Advances in 64Cu/67Cu-Based Radiopharmaceuticals

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10288943

Recent Advances in 64Cu/67Cu-Based Radiopharmaceuticals

About this item

Full title

Recent Advances in 64Cu/67Cu-Based Radiopharmaceuticals

Publisher

Basel: MDPI AG

Journal title

International journal of molecular sciences, 2023-05, Vol.24 (11), p.9154

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Copper-64 (T1/2 = 12.7 h) is a positron and beta-emitting isotope, with decay characteristics suitable for both positron emission tomography (PET) imaging and radiotherapy of cancer. Copper-67 (T1/2 = 61.8 h) is a beta and gamma emitter, appropriate for radiotherapy β-energy and with a half-life suitable for single-photon emission computed tomograp...

Alternative Titles

Full title

Recent Advances in 64Cu/67Cu-Based Radiopharmaceuticals

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10288943

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10288943

Other Identifiers

ISSN

1422-0067,1661-6596

E-ISSN

1422-0067

DOI

10.3390/ijms24119154

How to access this item